Eric Bjerkholt
Director Financiero/CFO en MIRUM PHARMACEUTICALS, INC. .
Fortuna: 615 485 $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Obi Greenman | M | 57 | 29 años | |
| Michael Grey | M | 71 | 6 años | |
| Christopher Peetz | M | 45 | 6 años | |
| Rachel Leheny | M | 60 | 5 años | |
| Lori L. Roll | F | - | 32 años | |
| Michael Dunn | M | 68 | 10 años | |
| David Woodhouse | M | 54 | 4 años | |
| Daniel Swisher | M | 61 | 13 años | |
| Timothy Kutzkey | M | 49 | 8 años | |
| Craig Parker | M | 63 | 6 años | |
| Laurence Corash | M | 80 | 33 años | |
| William Fairey | M | 60 | 3 años | |
| Sona Saira Ramasastry | F | 48 | 2 años | |
| Kevin Green | M | 52 | 18 años | |
| Vivek K. Jayaraman | M | 49 | 8 años | |
| Sudarshan Hebbar | M | 59 | 9 años | |
| Hua Shan | M | 63 | 2 años | |
| Anna Berkenblit | M | 54 | 6 años | |
| Ann Lucena | F | 37 | 3 años | |
| Mary Haak-Frendscho | M | 67 | 3 años | |
| Shao Lee Lin | M | 57 | 3 años | |
| Charles Williams | M | 46 | 4 años | |
| Alicia Goodman | F | - | 5 años | |
| Lon Cardon | M | 58 | 2 años | |
| Peter Radovich | M | 46 | 4 años | |
| Sophie Kornowski-Bonnet | M | 61 | 6 años | |
| Jami Nachtsheim | F | 65 | 5 años | |
| Allan Shaw | M | 59 | 1 años | |
| Carol Moore | F | 74 | 16 años | |
| Eric Roberts | M | 59 | 4 años | |
| Timothy Walbert | M | 57 | 1 años | |
| Robert Wilson | M | 83 | 1 años | |
| Fred Middleton | M | 74 | 4 años | |
| Frank R. Witney Witney | M | 70 | 10 años | |
| Patrick Heron | M | 53 | 6 años | |
| Kenneth Stauderman | M | 71 | 17 años | |
| Laura Brege | F | 66 | 5 años | |
| Mace Rothenberg | M | 67 | 3 años | |
| Laurent Fischer | M | 60 | 5 años | |
| Gail Schulze | F | 72 | 17 años | |
| Christopher Chai | M | 58 | 3 años | |
| Timothy Moore | M | 62 | 6 años | |
| Suzanne Margerum | F | - | 23 años | |
| Erin Campany | F | 57 | 2 años | |
| Richard Benjamin | M | 64 | 9 años | |
| Matthew Notarianni | M | - | - | |
| Maria Lacerca-Allen | M | 57 | 4 años | |
| Daniel Geffken | M | 67 | 1 años | |
| Erin Osborne Murphy | M | - | 4 años | |
| Joanne Quan | M | 60 | - | |
| John Dunn | M | 72 | 1 años | |
| Frédéric Guerard | M | 51 | 1 años | |
| Paul K. Ross | M | - | 4 años | |
| Pamela Vig | M | 53 | 6 años | |
| Douglas T. Sheehy | M | 57 |
Aimmune Therapeutics UK Ltd.
 Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Stallergenes Greer Ltd., Aimmune Therapeutics UK Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Cheltenham, UK. Aimmune Therapeutics was founded in 2015. | - |
| Lara Krupka-Longpre | F | 54 | 6 años | |
| Andrew McKibben | M | - | - | |
| Nina Mufti | M | - | 17 años | |
| Chrystal Menard | F | 53 | 12 años | |
| Andrew Cunningham | M | - | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Steven Ketchum | M | 59 |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 19 años |
| Dayton Misfeldt | M | 50 | 11 años | |
| Andrew Oxtoby | M | 50 | - | |
| Stephen Dilly | M | 64 | 4 años | |
| Ian John Massey | M | 73 |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 1 años |
| Jayson Dallas | M | 56 | 2 años | |
| Rodney Young | M | 61 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 8 años |
| Ernest Mario | M | 85 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 1 años |
| Ken Stratton | M | 55 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 14 años |
| Eric Dobmeier | M | 55 | 3 años | |
| Martin M. McGlynn | M | 78 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 15 años |
| Jennifer A. Troia | F | - | 12 años | |
| Geoffrey Parker | M | 59 | 1 años | |
| Jerel Davis | M | 47 | 5 años | |
| Steve Carchedi | M | 62 | 8 años | |
| Roger Perlmutter | M | 71 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 13 años |
| Brett K. Haumann | M | 54 | - | |
| Timothy Bruce Anderson | M | 77 | 18 años | |
| Parvinder S. Hyare | M | - | 7 años | |
| Krishnan Mahesh /davita/ | - | - | - | |
| Michelle Griffin | F | 58 | 3 años | |
| Stephen Nava | M | - | - | |
| Dolca Thomas | M | 53 | 3 años | |
| Stacey Seltzer | F | 47 | 5 años | |
| Stephen Huhn | M | 63 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | - |
| William D. Turner | M | 58 | 4 años | |
| Maria Millan | M | - |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | - |
| Mark Iwicki | M | 57 | 5 años | |
| John Kozarich | M | 74 | 8 años | |
| Homer Pearce | M | 71 | 15 años | |
| Bhaskar Chaudhuri | M | 69 | 8 años | |
| Ross Haghighat | M | 60 | 14 años | |
| James A. Wells | M | 73 | 10 años | |
| Robert Thomas | M | 62 | 11 años | |
| Kathryn Falberg | F | 63 | 5 años | |
| David Greenwood | M | 72 | 8 años | |
| Ronald Eastman | M | 71 | 11 años | |
| David Stump | M | 74 | 15 años | |
| Srini Akkaraju Akkaraju | M | 56 | 4 años | |
| Andrew King | M | 44 | 4 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 99 | 99.00% |
| Reino Unido | 1 | 1.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Eric Bjerkholt
- Red Personal